Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Timing your first automated investment depends on savings goals and risk comfort; starting early can compound gains over time with steady contributions.
15,330 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
As AI reshapes transportation, investors compare Uber Technologies and Lyft to gauge which company is better position...
When a CEO optimizes liquidity by selling shares, it sparks questions. This guide dives into xometry's (xmtr) recentl...
The housing market may feel stuck, with fewer bidding wars and rising delistings, but Opendoor is breaking through th...
Markets braces for resolution as headlines renew talk of an imminent Iran deal. This report tracks how investors pric...
Small modular reactor stocks trading under $10 can look tempting, but prices don’t always reflect real value. This gu...
Charles Schwab is partnering with Cboe to launch S&P 500 yes-or-no binary options, a first-of-its-kind move into pred...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
AI data centers are sparking a sweeping power expansion in the U.S. Three utility ETFs offer distinct routes to ride ...
SpaceX joining the Nasdaq-100 would be a major headline, but the real questions are about risk, weighting, and portfo...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...